You just read:

Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 data for DARZALEX® (daratumumab) and the Janssen Immuno-oncology Strategy and Portfolio

News provided by

Johnson & Johnson

Jul 07, 2016, 07:30 ET